IL17A and Hypertension: Inhibition of IL-17 signaling also ameliorated the progression of albuminuria and attenuated renal and vascular lymphocyte infiltration, thus suggesting that the inhibition of IL-17 may be a useful adjunct treatment for hypertension and the associated end-organ dysfunction [112].